https://investors.larimartx.com/ 2020-05-29T09:04:52-04:00 daily 1.0 https://investors.larimartx.com/committee-details/audit-committee 2025-10-13T16:42:48-04:00 0.5 https://investors.larimartx.com/committee-details/nominating-and-governance-committee 2023-10-04T10:03:51-04:00 0.5 https://investors.larimartx.com/committee-details/compensation-committee-charter 2025-10-13T16:43:53-04:00 0.5 https://investors.larimartx.com/committee-details/code-of-business-conduct-and-ethics 2018-12-13T10:57:34-05:00 0.5 https://investors.larimartx.com/committee-details/corporate-governance-guidelines 2017-04-18T09:04:16-04:00 0.5 https://investors.larimartx.com/events/event-details/44th-annual-jp-morgan-healthcare-conference 2025-12-18T17:44:54-05:00 0.5 https://investors.larimartx.com/events/event-details/leerink-global-healthcare-conference 2026-03-04T16:13:37-05:00 0.5 https://investors.larimartx.com/events/event-details/citizens-life-sciences-conference 2026-03-04T16:13:40-05:00 0.5 https://investors.larimartx.com/investor-relations 2020-05-29T09:04:52-04:00 0.8 https://investors.larimartx.com/press-releases 2020-05-26T15:57:37-04:00 0.8 https://investors.larimartx.com/events-and-presentations 2023-07-25T15:10:51-04:00 0.8 https://investors.larimartx.com/events-and-presentations/past-events 2023-07-25T15:30:12-04:00 0.8 https://investors.larimartx.com/events-and-presentations/presentations 2023-07-25T15:03:56-04:00 0.8 https://investors.larimartx.com/corporate-governance 2020-06-24T16:38:10-04:00 0.8 https://investors.larimartx.com/corporate-governance/committee-composition 2025-10-13T18:30:58-04:00 0.8 https://investors.larimartx.com/corporate-governance/contact-the-board 2017-03-21T09:31:03-04:00 0.8 https://investors.larimartx.com/financials-and-filings 2020-04-03T11:55:54-04:00 0.8 https://investors.larimartx.com/financial-information/sec-filings 2020-04-03T15:27:05-04:00 0.8 https://investors.larimartx.com/financial-information/annual-reports-and-proxy-materials 2020-07-10T14:51:09-04:00 0.8 https://investors.larimartx.com/corporate-governance/insider-ownership 2016-08-20T04:34:19-04:00 0.8 https://investors.larimartx.com/analyst-coverage 2025-08-05T14:08:29-04:00 0.8 https://investors.larimartx.com/stock-information/stock-quote-chart 2020-05-29T09:09:40-04:00 0.8 https://investors.larimartx.com/stock-information 2020-07-31T18:15:34-04:00 0.8 https://investors.larimartx.com/stock-information/historic-stock-lookup 2020-04-03T15:05:56-04:00 0.8 https://investors.larimartx.com/stock-information/investment-calculator 2020-04-03T15:12:02-04:00 0.8 https://investors.larimartx.com/investor-faqs 2020-05-14T10:06:52-04:00 0.8 https://investors.larimartx.com/email-alerts 2020-04-03T11:56:34-04:00 0.8 https://investors.larimartx.com/rss-news-feeds 2020-04-03T12:40:01-04:00 0.8 https://investors.larimartx.com/printed-materials 2017-03-14T03:15:19-04:00 0.8 https://investors.larimartx.com/contact-us 2020-04-01T15:14:39-04:00 0.8 https://investors.larimartx.com/email-alerts-unsubscribe 2017-03-18T06:57:06-04:00 0.8 https://investors.larimartx.com/form-8937 2020-07-10T16:26:29-04:00 0.8 https://investors.larimartx.com/news-releases/news-release-details/oxford-finance-and-midcap-financial-close-20-million-senior 2017-05-16T10:20:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-support-nord-observing-rare-disease-day 2017-05-16T10:20:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-initial-results-phase-2a-study-beloranib 2017-05-16T10:20:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-appoints-chief-commercial-officer-and-new-member-board 2017-05-16T10:20:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-secures-45-million-series-e-financing 2017-05-16T10:20:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-new-body-weight-loss-and-cardiometabolic-data 2017-05-16T10:20:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-appoints-20-year-biotechnology-industry-veteran-patricia 2017-05-16T10:20:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-initiation-phase-2a-clinical-development 2017-05-16T10:20:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-additional-weight-loss-and-cardiometabolic-data 2017-05-16T10:20:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-additional-weight-loss-and-cardiometabolic-0 2017-05-16T10:20:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-appoints-business-development-veteran-frances-k-heller 2017-05-16T10:20:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-obesity-society-29th-annual-scientific-meeting 2017-05-16T10:20:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-appoints-industry-executive-dennis-kim-md-mba-chief 2017-05-16T10:20:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-secures-33-million-series-c-financing 2017-05-16T10:20:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-cardiovascular-data-phase-1b-study-zgn-433 2017-05-16T10:20:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-biocentury-future-leaders-biotech-industry 2017-05-16T10:20:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-positive-topline-phase-1b-data-zgn-433-obesity 2017-05-16T10:20:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-presents-data-new-class-medicines-treat-obesity-american 2017-05-16T10:20:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-present-upcoming-conferences 2017-05-16T10:20:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-named-one-fierce-15-leading-biotech-companies-2009 2017-05-16T10:20:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-announces-participation-xsite-2009 2017-05-16T10:20:14-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/american-diabetes-association-awards-leaders-field 2017-05-16T10:20:14-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/groundbreaking-approach-treating-obesity-highlighted-keynote 2017-05-16T10:20:14-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-announces-participation-bio-2009-international 2017-05-16T10:20:14-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-appoints-matthias-jaffe-chief-financial-officer-and 2017-05-16T10:20:14-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-present-xconomy-forum 2017-05-16T10:20:14-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-present-upcoming-conferences-0 2017-05-16T10:20:14-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/argenta-discovery-and-zafgen-announce-contract-drug-discovery 2017-05-16T10:20:14-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-present-first-annual-boston-biotech-rd-conference 2017-05-16T10:20:14-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-appoints-industry-veteran-and-recognized-metabolic 2017-05-16T10:20:14-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-secures-21-million-series-d-financing 2017-05-16T10:20:18-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-new-weight-loss-and-safety-data-phase-2-study 2017-05-16T10:20:18-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-announces-pricing-initial-public-offering 2017-05-16T10:20:18-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-announces-closing-initial-public-offering-and-full 2017-05-16T10:20:18-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-appoints-new-member-board-directors 2017-05-16T10:20:18-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-appoints-patrick-loustau-president 2017-05-16T10:20:18-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-granted-orphan-drug-designation-european-union-beloranib 2017-05-16T10:20:18-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-second-quarter-2014 2017-05-16T10:20:18-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-34th-annual-canaccord-genuity-growth-conference 2017-05-16T10:20:18-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-second-quarter-2014-financial-results 2017-05-16T10:20:18-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/frances-k-heller-rejoins-zafgen-board-directors 2017-05-16T10:20:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-2014-leerink-partners-rare-disease-roundtable 2017-05-16T10:20:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-completes-enrollment-phase-2a-trial-beloranib 2017-05-16T10:20:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-initiation-phase-3-trial-beloranib-prader-willi 2017-05-16T10:20:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-third-quarter-2014-financial 2017-05-16T10:20:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-third-quarter-2014-financial-results 2017-05-16T10:20:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-initiation-phase-2b-trial-beloranib-severe 2017-05-16T10:20:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-added-nasdaq-biotechnology-index 2017-05-16T10:20:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-positive-results-phase-2-clinical-trial 2017-05-16T10:20:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-proposed-public-offering-common-stock 2017-05-16T10:20:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-pricing-public-offering-common-stock 2017-05-16T10:20:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-closing-public-offering-common-stock-and-full 2017-05-16T10:20:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-2015-leerink-global-healthcare-conference 2017-05-16T10:20:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-2015-rbc-capital-markets-conference 2017-05-16T10:20:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-cowen-and-company-35th-annual-health-care 2017-05-16T10:20:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-joins-nord-support-rare-disease-dayr 2017-05-16T10:20:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-new-weight-loss-and-safety-data-phase-2-trial 2017-05-16T10:20:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-fourth-quarter-and-full-year 2017-05-16T10:20:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-fourth-quarter-and-full-year-2014-financial 2017-05-16T10:20:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-first-quarter-2015-financial 2017-05-16T10:20:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-oral-and-poster-presentations-22nd-european 2017-05-16T10:20:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-presents-positive-safety-and-efficacy-data-phase-2-trial 2017-05-16T10:20:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-first-quarter-2015-financial-results 2017-05-16T10:20:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-appoints-global-head-medical-affairs-and-global-head 2017-05-16T10:20:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-completes-enrollment-us-phase-3-trial-beloranib-prader 2017-05-16T10:20:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-2015-bio-international-convention 2017-05-16T10:20:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-jmp-securities-life-sciences-conference-2015 2017-05-16T10:20:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-second-quarter-2015 2017-05-16T10:20:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-canaccord-genuity-35th-annual-growth-conference 2017-05-16T10:20:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-second-quarter-2015-financial-results 2017-05-16T10:20:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-completes-enrollment-phase-2b-trial-beloranib-severe 2017-05-16T10:20:35-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-morgan-stanley-global-healthcare-conference 2017-05-16T10:20:35-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-leerink-rare-disease-roundtable 2017-05-16T10:20:35-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-transition-board-directors 2017-05-16T10:20:35-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-granted-orphan-drug-designation-european-union-0 2017-05-16T10:20:35-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-issues-statement 2015-10-14T08:00:00-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-partial-clinical-hold-affecting-beloranib 2017-05-16T10:20:35-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-beloranib-program-update 2017-05-16T10:20:35-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-third-quarter-2015-financial 2015-11-03T11:01:31-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-third-quarter-2015-financial-results 2015-11-10T11:01:31-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-provides-clinical-update-beloranib 2015-12-02T01:30:27-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-beloranib-ind-placed-complete-clinical-hold 2015-12-02T14:24:48-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgens-pivotal-phase-3-trial-beloranib-prader-willi-syndrome 2016-01-20T01:00:24-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-upcoming-investor-conferences 2016-02-02T02:00:26-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-participate-upcoming-investor-conferences 2016-02-16T11:05:25-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgens-phase-2b-trial-beloranib-severe-obesity-complicated-type 2016-02-18T01:30:26-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-joins-nord-raising-awareness-rare-disease-day 2017-05-16T10:20:40-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-cowen-company-36th-annual-health-care-conference 2016-03-01T02:00:17-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-fourth-quarter-and-full-0 2016-03-02T11:00:27-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-adds-thomas-o-daniel-md-its-board-directors 2016-03-08T02:00:50-05:00 0.5 https://investors.larimartx.com/node/7371 2016-03-09T11:05:36-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-data-bestpws-study-beloranib-prader-willi 2016-03-28T12:05:32-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-presents-new-data-phase-3-bestpws-study-evaluating 2016-04-03T09:15:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-first-quarter-2016-financial 2016-05-03T12:05:19-04:00 0.5 https://investors.larimartx.com/node/7391 2016-05-10T12:05:23-04:00 0.5 https://investors.larimartx.com/node/7396 2016-06-11T07:00:21-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-refocuses-resources-development-differentiated-second 2016-07-19T12:05:16-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-canaccord-genuitys-36th-annual-growth-conference 2016-08-03T13:00:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-second-quarter-2016-financial-results 2016-08-04T12:05:14-04:00 0.5 https://investors.larimartx.com/node/7416 2016-09-20T02:59:58-04:00 0.5 https://investors.larimartx.com/node/7421 2016-11-09T11:05:18-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-leerink-partners-6th-annual-global-healthcare 2017-02-09T11:05:14-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-upcoming-investor-conferences-0 2017-02-28T11:05:23-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-fourth-quarter-and-full-1 2017-03-02T11:05:11-05:00 0.5 https://investors.larimartx.com/node/7441 2017-05-16T10:29:08-04:00 0.5 https://investors.larimartx.com/node/8691 2017-05-16T10:12:55-04:00 0.5 https://investors.larimartx.com/node/8736 2017-05-16T10:31:02-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-two-late-breaking-abstracts-zgn-1061-american 2017-06-06T16:35:33-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-presents-new-data-highlighting-potential-zgn-1061 2017-06-10T13:10:25-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-jmp-securities-life-sciences-conference 2017-06-13T16:19:54-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-second-quarter-2017 2017-08-01T16:14:03-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-canaccord-genuity-37th-annual-growth-conference 2017-08-02T16:14:55-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-second-quarter-2017-financial-results 2017-08-08T16:10:47-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-presents-new-preclinical-data-zgn-1061-53rd-annual 2017-09-12T08:03:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-initiates-phase-2-clinical-trial-zgn-1061-patients-type-2 2017-09-12T16:10:18-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-2017-ladenburg-thalmann-healthcare-conference 2017-09-19T16:11:42-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-appoints-jeffrey-hatfield-chief-executive-officer-thomas 2017-10-10T07:03:07-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-inducement-grant-under-nasdaq-listing-rule-5635c4 2017-10-12T17:03:37-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-third-quarter-2017-financial-results 2017-11-07T16:57:02-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-strong-clinical-progress-and-updates-outlook-2018 2018-01-05T10:12:27-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-leerink-partners-7th-annual-global-healthcare 2018-02-08T16:01:56-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-fourth-quarter-and-full-2 2018-03-01T16:33:06-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-fourth-quarter-and-full-year-2017-financial 2018-03-06T16:08:02-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-cowen-38th-annual-health-care-conference 2018-03-07T16:31:17-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-first-quarter-2018-financial 2018-05-01T16:33:32-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-deutsche-bank-43rd-annual-health-care-conference 2018-05-02T16:32:58-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-first-quarter-2018-operating-and-financial 2018-05-08T16:07:45-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-expands-executive-leadership-team-appointment-brian 2018-05-30T07:04:05-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-appoints-industry-veteran-and-healthcare-policy 2018-06-07T07:03:13-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-positive-full-results-phase-2-proof-concept 2018-06-23T10:01:58-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/reminder-zafgen-host-zgn-1061-phase-2-data-conference-call 2018-06-25T07:03:46-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-set-join-russell-3000r-index 2018-06-25T07:08:46-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-proposed-offering-common-stock 2018-06-27T16:03:39-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-pricing-offering-common-stock 2018-06-28T08:09:54-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-closing-offering-common-stock-and-exercise-full 2018-07-02T16:09:02-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-and-foundation-prader-willi-research-announce-path-pws 2018-07-09T08:02:34-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-second-quarter-2018 2018-07-31T16:07:25-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-canaccord-genuity-38th-annual-growth-conference 2018-08-01T16:17:38-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-departure-president-and-chief-scientific 2018-08-02T16:09:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-second-quarter-2018-operating-and-financial 2018-08-07T16:07:40-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-wedbush-pacgrow-healthcare-conference 2018-08-08T16:09:02-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-data-multiple-nonclinical-ind-enabling-studies 2018-10-18T13:54:41-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-third-quarter-2018-financial 2018-11-01T08:05:41-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-stifel-2018-healthcare-conference 2018-11-06T16:08:26-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-third-quarter-2018-operating-and-financial 2018-11-07T16:08:46-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-30th-annual-piper-jaffray-healthcare-conference 2018-11-21T16:07:16-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-provides-update-investigational-new-drug-application-zgn 2018-11-26T07:02:51-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-positive-results-second-cohort-phase-2-clinical 2019-01-17T07:04:53-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-strengthens-executive-leadership-team-appointment 2019-03-04T07:08:28-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-host-conference-call-discuss-fourth-quarter-and-full-3 2019-03-06T18:01:58-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-cowen-and-company-39th-annual-health-care 2019-03-07T08:10:08-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-fourth-quarter-and-full-year-2018-operating-and 2019-03-11T16:09:16-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-31st-annual-roth-conference 2019-03-13T17:01:42-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-inc-reports-inducement-grant-under-nasdaq-listing-rule 2019-04-04T16:35:23-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announce-first-quarter-2019-financial-results 2019-05-02T16:31:19-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-first-quarter-2019-operating-and-financial 2019-05-09T16:16:11-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-regulatory-update-zgn-1061 2019-05-30T07:01:12-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-presented-full-results-phase-2-clinical-trial-zgn-1061 2019-06-10T07:01:09-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-jmp-securities-life-sciences-conference-0 2019-06-13T16:16:21-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-announces-agreement-us-food-and-drug-administration-new 2019-07-24T16:17:02-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-present-wedbush-pacgrow-healthcare-conference-0 2019-08-06T16:15:53-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-second-quarter-2019-operating-and-financial 2019-08-08T16:16:44-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-explore-strategic-alternatives 2019-09-05T07:01:29-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-reports-third-quarter-2019-financial-results 2019-11-06T16:02:21-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/zafgen-and-chondrial-therapeutics-announce-definitive-merger 2019-12-18T06:00:46-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/chondrial-therapeutics-and-zafgen-complete-merger-and-begin 2020-05-29T08:02:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-jefferies-virtual-healthcare 2020-05-29T16:06:05-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-dosing-patients-third-cohort 2020-07-20T16:15:47-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-positive-opinion-orphan-drug 2020-07-28T08:01:56-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-2020-wedbush-pacgrow-healthcare 2020-08-04T08:02:17-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-second-quarter-2020-operating-and 2020-08-11T07:01:20-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-morgan-stanley-virtual-18th-annual 2020-09-10T08:01:54-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-oppenheimer-fall-healthcare-life 2020-09-21T09:58:32-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-formation-scientific-advisory 2020-10-13T08:01:32-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-third-quarter-2020-operating-and 2020-11-10T08:02:43-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-participate-upcoming-investor-conferences 2020-11-13T08:01:25-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-completion-dosing-single 2020-12-08T07:30:53-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-added-nasdaq-biotechnology-index 2020-12-15T08:00:49-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-svb-leerink-10th-annual-global 2021-02-18T16:01:52-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-fourth-quarter-and-full-year-2020 2021-03-04T07:00:43-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-first-quarter-2021-operating-and 2021-05-10T16:07:38-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-positive-topline-phase-1-clinical 2021-05-11T07:02:41-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-receives-european-medicines-agency-priority 2021-05-20T16:32:25-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-95-million-private-placement 2021-05-21T09:19:17-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-fda-clinical-hold-cti-1601-and 2021-05-25T17:42:33-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-jmp-securities-life-sciences 2021-06-11T07:00:59-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-william-blair-biotech-focus 2021-07-08T16:01:49-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-second-quarter-2021-operating-and 2021-08-12T07:02:35-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-upcoming-oral-presentation-world 2021-08-19T07:00:56-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-morgan-stanley-19th-annual-global 2021-09-08T15:51:37-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-participate-svb-leerink-cyberx-series 2021-09-16T08:00:51-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-third-quarter-2021-operating-and 2021-11-12T07:05:19-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-participate-guggenheim-virtual 2021-11-15T07:01:11-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-participate-piper-sandler-33rd-annual 2021-11-22T07:01:28-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-provides-update-cti-1601-clinical-program 2022-02-14T16:02:48-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-fourth-quarter-and-full-year-2021 2022-03-25T07:03:10-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-first-quarter-2022-operating-and 2022-05-12T07:01:28-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-upcoming-poster-presentations-4th 2022-05-19T08:00:39-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-upcoming-scientific-conference 2022-06-02T08:00:27-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-oral-presentation-upcoming-gordon 2022-06-28T08:00:45-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-presentation-upcoming-gordon 2022-07-28T16:08:40-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-provides-updates-cti-1601-clinical-program 2022-08-11T16:07:37-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-fda-clearance-initiate-25-mg 2022-09-14T07:01:26-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-70-million-underwritten-offering 2022-09-14T07:06:20-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-closing-underwritten-offering-and 2022-09-16T13:00:22-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-oral-and-poster-presentations 2022-10-19T16:05:24-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-issuance-us-patent-providing 2022-10-20T08:01:11-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-participate-guggenheim-4th-annual 2022-11-07T16:05:42-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-third-quarter-2022-operating-and 2022-11-10T07:00:41-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-34th-annual-piper-sandler 2022-11-21T16:05:26-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-appoints-dr-gopi-shankar-chief-development 2023-02-07T16:07:12-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-fourth-quarter-and-full-year-2022 2023-03-14T07:00:51-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-participate-guggenheim-genomic-medicines 2023-03-28T16:06:01-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-preliminary-top-line-data-phase-2 2023-05-15T07:00:48-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-set-join-russell-3000r-index 2023-06-21T16:05:19-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-appoints-dr-rusty-clayton-chief-medical 2023-07-17T16:05:29-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-receives-fda-clearance-proceed-50-mg-cohort 2023-07-25T07:00:43-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-second-quarter-2023-operating-and 2023-08-10T07:01:03-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-citi-18th-annual-biopharma 2023-08-31T16:06:07-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-appoints-dr-jeffrey-w-sherman-its-board 2023-10-04T10:10:04-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-guggenheim-5th-annual-inflammation 2023-11-01T16:07:14-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-third-quarter-2023-operating-and 2023-11-14T07:05:03-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-positive-top-line-data-phase-2-dose 2024-02-12T07:00:40-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-proposed-underwritten-public 2024-02-13T16:18:48-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-pricing-underwritten-public 2024-02-14T06:15:12-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-closing-underwritten-public 2024-02-16T16:20:25-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-leerink-partners-global-biopharma 2024-03-06T16:08:03-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-dosing-first-patient-long-term 2024-03-11T16:05:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-fourth-quarter-and-full-year-2023 2024-03-14T16:05:39-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-first-quarter-2024-operating-and 2024-05-09T07:00:38-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-fda-has-removed-partial-clinical 2024-05-20T16:05:56-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-selected-fda-participate-start-pilot 2024-05-30T16:05:32-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-second-quarter-2024-operating-and 2024-08-07T07:00:42-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-participate-upcoming-investor-conferences-0 2024-08-27T08:01:28-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-three-poster-presentations 2024-09-19T07:00:41-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-third-quarter-2024-operating-and 2024-10-30T07:00:55-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-presents-additional-data-phase-1-studies 2024-11-18T07:01:19-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-positive-initial-data-ongoing 2024-12-16T07:00:47-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-dosing-adolescents-nomlabofusp 2025-01-23T16:05:37-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-leerink-partners-global-healthcare 2025-03-03T16:06:01-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-provides-nomlabofusp-development-update-and 2025-03-24T07:00:50-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-first-quarter-2025-financial 2025-04-30T07:00:28-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-regulatory-update-call 2025-06-20T16:05:30-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-fda-recommendations-safety 2025-06-23T07:00:45-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-publishes-nonclinical-data-supporting 2025-07-08T07:00:43-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-proposed-underwritten-public-0 2025-07-29T16:02:08-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-pricing-underwritten-public-0 2025-07-29T23:51:08-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-closing-underwritten-public-0 2025-07-31T16:15:17-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-second-quarter-2025-financial 2025-08-14T07:01:08-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-conference-call-nomlabofusp 2025-09-28T17:00:21-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-positive-data-ongoing-long-term 2025-09-29T07:00:31-04:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-third-quarter-2025-financial 2025-11-05T07:01:54-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-present-44th-annual-jp-morgan-healthcare 2025-12-18T08:01:32-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-fda-breakthrough-therapy 2026-02-24T07:01:06-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-proposed-75-million-underwritten 2026-02-25T16:01:22-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-pricing-upsized-100-million 2026-02-25T21:00:07-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-participate-upcoming-investor-conferences-1 2026-03-04T16:05:31-05:00 0.5 https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-fourth-quarter-and-full-year-2025 2026-03-19T07:03:04-04:00 0.5 https://investors.larimartx.com/sec-filings/sec-filing/d/0001374690-10-000003 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/da/0001374690-10-000004 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/d/0001374690-11-000001 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/d/0001374690-12-000001 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/d/0001374690-12-000003 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/regdex/9999999997-06-037547 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/regdex/9999999997-08-001413 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/regdex/9999999997-08-045467 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-1/0001193125-14-149201 2017-03-29T09:36:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-1a/0001193125-14-163502 2017-03-29T09:36:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-1a/0001193125-14-180379 2017-03-29T09:38:18-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-1a/0001193125-14-222253 2017-03-29T09:38:18-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-1a/0001193125-14-227208 2017-03-29T09:39:49-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-1a/0001193125-14-237843 2017-03-29T09:39:49-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-a12b/0001193125-14-240257 2017-03-29T09:40:51-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/certnas/9999999997-14-011214 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042456 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042457 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042458 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042460 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042459 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042461 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042462 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042463 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042464 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042465 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042467 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042466 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-042468 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-1mef/0001193125-14-241485 2017-03-29T09:42:34-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/effect/9999999995-14-001812 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b4/0001193125-14-242054 2017-03-29T09:42:47-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-14-242275 2017-03-29T09:43:29-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/ct-order/9999999997-14-011353 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-14-043154 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-14-247362 2017-03-29T09:43:44-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-14-043819 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-14-043817 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-14-043823 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-14-043831 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-14-043835 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-14-043833 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-14-043837 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0000315066-14-003619 2017-03-29T09:44:46-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-14-308397 2017-03-29T09:44:58-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-14-310145 2017-03-29T09:44:58-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-14-345190 2017-03-29T09:45:26-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001209191-14-058528 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-14-065809 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-14-409480 2017-03-29T09:46:01-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-14-411306 2017-03-29T09:46:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-14-421986 2017-03-29T09:46:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-1/0001193125-15-006755 2017-03-29T09:46:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-008051 2017-03-29T09:46:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-15-003796 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-15-003797 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-15-003798 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-15-003799 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-1a/0001193125-15-013409 2017-03-29T09:48:19-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-1a/0001193125-15-017574 2017-03-29T09:48:19-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-1mef/0001193125-15-017881 2017-03-29T09:49:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/effect/9999999995-15-000181 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b4/0001193125-15-018702 2017-03-29T09:49:19-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001104659-15-009389 2017-03-29T09:49:19-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001596770-15-000024 2017-03-29T09:49:49-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000315066-15-002444 2017-03-29T09:49:49-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001072613-15-000136 2017-03-29T09:50:01-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-15-021907 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-15-021905 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-15-021908 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-15-021909 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-098566 2017-03-29T09:51:31-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-15-028009 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/node/7811 2017-03-29T10:31:38-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001012975-15-000245 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001012975-15-000247 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001104659-15-023039 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/def-14a/0001193125-15-162486 2017-03-29T09:52:38-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-184006 2017-03-29T09:53:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-15-188267 2017-03-29T09:53:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001012975-15-000417 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001012975-15-000418 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-15-049837 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-15-221988 2017-03-29T09:53:51-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001209191-15-052958 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-243076 2017-03-29T09:55:04-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-001266 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-001265 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-001267 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-001270 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-001271 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-001269 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-001272 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001012975-15-000553 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001012975-15-000552 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-286431 2017-03-29T09:56:17-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-15-291736 2017-03-29T09:56:34-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-004906 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-004979 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-005118 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-005119 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-005120 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-005348 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001012975-15-000684 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0000899243-15-005463 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0000899243-15-005464 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-005466 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-005465 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-334035 2017-03-29T09:59:23-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-344249 2017-03-29T09:59:23-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-345224 2017-03-29T09:59:38-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4a/0000899243-15-006923 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4a/0000899243-15-006924 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-350689 2017-03-29T09:59:58-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001144204-15-060510 2017-03-29T10:00:17-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-007343 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-15-007344 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-373450 2017-03-29T10:00:30-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-15-377065 2017-03-29T10:00:44-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001193805-15-001953 2017-03-29T10:00:44-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-392535 2017-03-29T10:01:12-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-15-393540 2017-03-29T10:01:12-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001193805-15-002089 2017-03-29T10:01:28-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-011435 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-16-433718 2017-03-29T10:01:46-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-012286 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-012289 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-012287 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-012288 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001193805-16-002326 2017-03-29T10:02:13-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001193125-16-457607 2017-03-29T10:04:43-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0000038777-16-000457 2017-03-29T10:04:43-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001193805-16-002539 2017-03-29T10:06:38-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-16-002544 2017-03-29T10:06:38-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001193805-16-002543 2017-03-29T10:07:03-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000315066-16-005603 2017-03-29T10:07:03-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001104659-16-096356 2017-03-29T10:07:21-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001144204-16-081322 2017-03-29T10:07:21-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001596770-16-000112 2017-03-29T10:07:38-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0000093751-16-000343 2017-03-29T10:07:38-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-16-002674 2017-03-29T10:07:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-16-467681 2017-03-29T10:07:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-16-496916 2017-03-29T10:08:10-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-16-498452 2017-03-29T10:08:10-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0000899243-16-015734 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-k/0001193125-16-505173 2017-03-29T10:08:29-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-16-505212 2017-03-29T10:09:11-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-017486 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-017488 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-017489 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-017490 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-017487 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-017491 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-017492 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000093751-16-000573 2017-03-29T10:10:10-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-017987 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-ka/0001193125-16-569327 2017-03-29T10:10:21-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/def-14a/0001193125-16-577958 2017-03-29T10:10:21-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-16-585593 2017-03-29T10:10:46-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-16-585718 2017-03-29T10:10:46-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-16-640536 2017-03-29T10:11:15-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-024063 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-024064 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-024068 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-024070 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-024069 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-024066 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-024065 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-024067 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-16-651297 2017-03-29T10:12:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-025723 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-025724 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-025726 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-16-003655 2017-03-29T10:12:33-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001193805-16-003656 2017-03-29T10:12:47-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-16-671803 2017-03-29T10:12:47-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-16-672131 2017-03-29T10:13:07-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-028277 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-16-764348 2017-03-29T10:13:40-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-16-764420 2017-03-29T10:13:40-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-033799 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-16-036035 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-002289 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-002287 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-002288 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000038777-17-000093 2017-03-29T10:14:33-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001104659-17-007838 2017-03-29T10:14:45-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000093751-17-000201 2017-03-29T10:14:45-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001144204-17-008133 2017-03-29T10:14:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000315066-17-002162 2017-03-29T10:14:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-004091 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-004098 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-004094 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-004099 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-004101 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-004102 2021-07-09T20:00:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-17-076883 2017-03-09T16:18:22-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-17-078789 2017-03-10T16:27:58-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-k/0001193125-17-078784 2017-03-10T16:27:58-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/def-14a/0001193125-17-148291 2017-04-28T16:42:23-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-17-158697 2017-05-04T16:31:20-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-17-164232 2017-05-09T16:32:14-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-17-164257 2017-05-09T16:44:11-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-012901 2017-05-11T19:04:30-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-013254 2017-05-15T20:32:17-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-017085 2017-06-23T16:23:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-017084 2017-06-23T16:23:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-017079 2017-06-23T16:23:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-017077 2017-06-23T16:23:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-017073 2017-06-23T16:23:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-017076 2017-06-23T16:23:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-017069 2017-06-23T16:23:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-017070 2017-06-23T16:23:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-17-211752 2017-06-23T16:23:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-018210 2017-07-12T16:14:53-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-17-251371 2017-08-08T16:29:40-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-3/0001193125-17-252848 2017-08-09T16:44:17-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-17-252840 2017-08-09T16:44:17-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/effect/9999999995-17-002187 2017-08-24T06:16:40-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-024049 2017-10-11T18:07:09-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0000899243-17-024051 2017-10-11T18:11:09-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-024054 2017-10-11T18:17:10-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-17-308904 2017-10-12T17:14:23-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-024381 2017-10-17T17:15:28-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-17-335861 2017-11-07T17:00:24-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-17-335910 2017-11-07T17:19:25-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-17-029728 2017-12-29T16:35:27-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-004559 2018-01-05T16:49:48-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-000593 2018-01-05T17:02:46-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-000592 2018-01-05T17:02:46-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-000591 2018-01-05T17:03:48-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-000596 2018-01-05T17:05:48-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-000594 2018-01-05T17:06:47-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-000595 2018-01-05T17:06:52-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001104659-18-008108 2018-02-12T06:58:36-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000315066-18-001661 2018-02-13T10:15:24-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-005332 2018-02-23T17:15:18-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-005331 2018-02-23T17:15:19-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-005333 2018-02-23T17:17:20-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-005337 2018-02-23T17:23:22-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-072113 2018-03-06T16:18:22-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-k/0001193125-18-077456 2018-03-09T16:52:05-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-18-077480 2018-03-09T16:56:59-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-006980 2018-03-09T18:07:05-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/def-14a/0001193125-18-121231 2018-04-18T17:26:26-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-155978 2018-05-08T16:18:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-18-159281 2018-05-10T16:48:18-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-178715 2018-05-30T17:21:17-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0000899243-18-014476 2018-05-30T17:33:17-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-014478 2018-05-30T17:35:16-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-186943 2018-06-07T17:14:59-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0000899243-18-015544 2018-06-07T17:31:58-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-015550 2018-06-07T17:36:55-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-015551 2018-06-07T17:36:55-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-015549 2018-06-07T17:36:55-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-015555 2018-06-07T17:40:55-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-015554 2018-06-07T17:40:55-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-015557 2018-06-07T17:45:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-015560 2018-06-07T17:48:55-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-201664 2018-06-25T07:18:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b5/0001193125-18-205824 2018-06-27T16:53:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b5/0001193125-18-207757 2018-06-28T16:58:26-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-207787 2018-06-28T17:07:25-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-18-018764 2018-06-29T19:04:28-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001104659-18-043521 2018-07-02T16:19:14-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0000930413-18-002157 2018-07-09T16:07:03-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-236631 2018-08-02T16:30:34-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-241169 2018-08-07T16:27:40-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-18-244422 2018-08-09T16:39:29-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000315066-18-002167 2018-08-10T11:22:54-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-320926 2018-11-07T16:21:07-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001564590-18-028944 2018-11-09T16:38:14-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-18-323849 2018-11-09T16:46:06-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-3/0001193125-18-323855 2018-11-09T16:50:07-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b5/0001193125-18-323862 2018-11-09T16:54:08-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-323890 2018-11-09T17:22:10-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/effect/9999999995-18-002946 2018-11-21T06:04:17-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-18-333393 2018-11-26T07:22:00-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-010961 2019-01-17T07:34:50-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-001925 2019-01-24T20:27:41-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-001928 2019-01-24T20:29:41-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-001927 2019-01-24T20:29:41-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-001926 2019-01-24T20:29:41-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-002065 2019-01-28T19:05:01-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-002062 2019-01-28T19:05:01-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-002061 2019-01-28T19:05:02-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-002064 2019-01-28T19:05:02-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-002067 2019-01-28T19:09:01-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0000215457-19-006595 2019-02-08T06:09:05-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001104659-19-006474 2019-02-08T06:23:09-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000315066-19-001418 2019-02-13T12:20:18-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000930413-19-000562 2019-02-14T16:08:15-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-042548 2019-02-15T17:04:59-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-070841 2019-03-11T16:16:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0000899243-19-007065 2019-03-11T18:23:05-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-k/0001564590-19-007863 2019-03-14T17:31:01-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-19-075029 2019-03-14T17:32:58-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0000919574-19-002595 2019-03-25T17:24:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-097949 2019-04-04T16:53:12-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-010033 2019-04-04T18:41:16-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/def-14a/0001193125-19-122675 2019-04-26T17:32:58-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-143016 2019-05-09T16:35:01-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001564590-19-018086 2019-05-09T17:08:57-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-160233 2019-05-30T07:24:35-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-172590 2019-06-13T17:18:32-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-018474 2019-06-27T19:36:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-018476 2019-06-27T19:36:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-018480 2019-06-27T19:38:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-018479 2019-06-27T19:38:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-018481 2019-06-27T19:38:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-018483 2019-06-27T19:40:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-19-018485 2019-06-27T19:44:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000215457-19-008360 2019-07-10T16:34:43-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-216900 2019-08-08T16:51:13-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001564590-19-030904 2019-08-08T17:57:19-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001387131-19-006222 2019-08-16T13:33:30-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-244019 2019-09-12T17:22:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001013594-19-000528 2019-09-16T16:58:55-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001387131-19-007012 2019-09-18T15:37:05-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-249639 2019-09-19T17:07:42-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000315066-19-001729 2019-10-10T16:26:07-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0000935836-19-000550 2019-10-15T17:13:09-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-285939 2019-11-06T16:33:00-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001564590-19-041090 2019-11-06T16:48:41-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-19-287477 2019-11-07T17:33:11-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/defa14a/0001193125-19-316829 2019-12-18T08:15:28-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-19-316828 2019-12-18T08:17:48-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/defa14a/0001193125-19-317565 2019-12-18T16:39:04-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001387131-19-009675 2019-12-19T12:40:30-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13d/0001193125-19-325057 2019-12-30T09:29:26-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/defa14a/0001193125-20-005894 2020-01-13T07:19:18-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-005893 2020-01-13T07:21:38-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001104659-20-010544 2020-02-04T15:13:17-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-025413 2020-02-05T16:44:40-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/defa14a/0001193125-20-025418 2020-02-05T16:47:00-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001178913-20-000349 2020-02-11T12:22:08-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001037389-20-000021 2020-02-12T12:13:57-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001013594-20-000130 2020-02-13T10:08:37-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000919574-20-001448 2020-02-14T11:40:10-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000935836-20-000136 2020-02-14T14:13:58-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001214659-20-001478 2020-02-14T16:08:54-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001172661-20-000851 2020-02-14T16:53:26-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-063097 2020-03-05T16:21:00-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-k/0001564590-20-008984 2020-03-05T16:34:39-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-20-063154 2020-03-05T16:44:58-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/prem14a/0001193125-20-065266 2020-03-06T17:35:45-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/defa14a/0001193125-20-065289 2020-03-09T06:06:50-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-065288 2020-03-09T06:07:10-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/prer14a/0001193125-20-103893 2020-04-10T16:44:07-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-119225 2020-04-24T17:04:22-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/prer14a/0001193125-20-120402 2020-04-27T09:32:41-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/defm14a/0001193125-20-125890 2020-04-29T15:23:11-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001564590-20-022942 2020-05-07T16:41:24-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/defa14a/0001193125-20-145379 2020-05-19T06:06:36-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-157924 2020-06-02T07:58:05-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/upload/0000000000-20-003699 2020-06-03T00:06:09-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/upload/0000000000-20-002953 2020-06-03T00:06:12-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/corresp/0001193125-20-103896 2020-06-03T00:06:18-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/corresp/0001193125-20-120405 2020-06-03T00:06:21-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/upload/0000000000-20-003534 2020-06-03T00:06:23-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-158916 2020-06-03T06:05:40-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001387131-20-005502 2020-06-05T16:23:18-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001192482-20-000422 2020-06-05T19:19:10-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001192482-20-000424 2020-06-05T19:46:51-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001192482-20-000427 2020-06-05T19:52:12-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001192482-20-000430 2020-06-05T19:55:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001192482-20-000433 2020-06-05T20:07:39-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000435 2020-06-05T20:07:40-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001192482-20-000439 2020-06-05T20:15:53-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13d/0001193805-20-000670 2020-06-08T17:15:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13d/0001193125-20-163701 2020-06-08T17:23:31-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001193805-20-000673 2020-06-08T18:04:58-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/d/0001192482-20-000457 2020-06-10T13:04:32-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/d/0001192482-20-000456 2020-06-10T13:05:38-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001213900-20-014711 2020-06-11T17:12:59-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-ka/0001193125-20-181113 2020-06-26T17:10:42-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-20-181158 2020-06-26T17:30:28-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-3/0001193125-20-181162 2020-06-26T17:34:10-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13da/0001193125-20-184105 2020-06-30T16:48:13-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000586 2020-06-30T17:03:05-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000587 2020-06-30T17:04:38-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000588 2020-06-30T17:04:44-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13da/0001193805-20-000766 2020-07-01T16:03:33-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/effect/9999999995-20-001802 2020-07-15T06:28:05-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-211426 2020-08-06T09:04:54-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-215639 2020-08-11T07:41:26-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/upload/0000000000-20-006250 2020-08-12T00:09:18-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/corresp/0001193125-20-192119 2020-08-12T00:09:23-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001564590-20-040314 2020-08-14T16:50:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-ka/0001193125-20-220561 2020-08-14T16:59:03-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-3/0001193125-20-220606 2020-08-14T17:30:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/def-14a/0001193125-20-224087 2020-08-19T06:11:47-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/defa14a/0001193125-20-224092 2020-08-19T06:16:45-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/effect/9999999995-20-002332 2020-09-02T06:06:17-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-257168 2020-09-29T07:10:04-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-ka/0001193125-20-257868 2020-09-29T16:41:40-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000736 2020-09-30T13:53:34-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000738 2020-09-30T13:55:20-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000740 2020-09-30T14:01:48-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000742 2020-09-30T14:03:02-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000745 2020-09-30T14:08:39-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000747 2020-09-30T14:13:42-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000749 2020-09-30T14:15:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-20-000751 2020-09-30T14:18:44-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/corresp/0001193125-20-236337 2020-10-01T00:22:59-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/upload/0000000000-20-007931 2020-10-01T00:24:51-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-20-001219 2020-10-01T16:30:59-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-20-262644 2020-10-02T17:22:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-282731 2020-10-30T17:05:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-290185 2020-11-10T16:25:47-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001564590-20-053618 2020-11-12T16:47:52-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-ka/0001193125-20-291777 2020-11-12T16:55:44-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-20-312288 2020-12-08T07:45:37-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-21-000075 2021-01-21T10:59:42-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-21-000074 2021-01-21T11:00:18-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001104659-21-010775 2021-02-02T13:08:18-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001037389-21-000115 2021-02-11T06:07:38-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0000947871-21-000178 2021-02-12T16:58:41-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001493152-21-003768 2021-02-16T06:37:02-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001178913-21-000597 2021-02-16T09:03:00-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001214659-21-001842 2021-02-16T13:07:18-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001013594-21-000163 2021-02-16T15:13:53-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001104659-21-024228 2021-02-16T16:51:49-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0000935836-21-000176 2021-02-16T17:24:57-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001085146-21-001060 2021-03-02T14:02:54-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-068478 2021-03-04T07:33:49-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-k/0001564590-21-011003 2021-03-04T17:13:03-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-ka/0001193125-21-069725 2021-03-04T17:19:15-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/def-14a/0001193125-21-115586 2021-04-14T09:10:49-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-156249 2021-05-10T16:20:33-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001564590-21-026084 2021-05-10T16:35:55-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-157048 2021-05-11T08:38:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-162647 2021-05-17T06:37:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-21-000441 2021-05-17T17:11:02-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-21-000685 2021-05-17T17:20:26-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-21-000440 2021-05-18T00:07:03-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-21-000442 2021-05-18T00:55:35-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-21-000438 2021-05-18T00:59:26-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-21-000439 2021-05-18T01:04:04-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-165178 2021-05-18T15:14:53-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-21-000445 2021-05-20T08:52:16-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-168548 2021-05-21T07:32:09-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-168704 2021-05-21T09:32:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13da/0001193805-21-000700 2021-05-21T17:08:29-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-173167 2021-05-26T10:20:32-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13da/0001193805-21-000725 2021-05-26T13:49:29-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-190213 2021-06-14T17:24:02-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-205474 2021-07-01T06:16:54-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001192482-21-000601 2021-07-02T16:10:35-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-21-000974 2021-07-02T17:09:03-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13da/0001193805-21-000975 2021-07-02T17:11:09-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001564590-21-043701 2021-08-12T10:33:25-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-244068 2021-08-12T10:33:28-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/drsa/0000950123-14-003150 2021-10-02T09:30:12-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/corresp/0001193125-14-243707 2021-10-02T11:35:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/corresp/0001193125-14-237917 2021-10-02T15:36:35-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/upload/0000000000-14-015416 2021-10-02T17:15:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/drs/0000950123-14-000919 2021-10-02T17:57:10-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/corresp/0001193125-14-237902 2021-10-02T18:27:01-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/corresp/0001193125-18-329003 2021-10-03T00:56:04-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/upload/0000000000-18-035368 2021-10-03T01:08:46-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/upload/0000000000-14-010230 2021-10-03T01:48:58-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/corresp/0001193125-17-263712 2021-10-03T02:13:46-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/upload/0000000000-17-028702 2021-10-03T02:54:21-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-21-327323 2021-11-12T07:24:41-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-21-004331 2021-11-12T13:00:17-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-001320 2022-01-20T19:22:22-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-001319 2022-01-20T19:22:29-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001085146-22-000831 2022-02-11T11:36:09-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000947871-22-000203 2022-02-11T16:43:46-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001213900-22-007092 2022-02-11T17:37:17-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001104659-22-022752 2022-02-14T16:28:26-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-22-042209 2022-02-14T17:58:43-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000935836-22-000194 2022-02-15T14:44:51-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001493152-22-004967 2022-02-18T16:35:06-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-22-055857 2022-02-28T08:19:09-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-22-084528 2022-03-25T07:13:41-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-k/0000950170-22-004637 2022-03-25T12:42:13-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-22-101650 2022-04-11T16:08:28-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/def-14a/0001193125-22-102289 2022-04-12T06:09:24-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-22-000771 2022-05-11T17:44:02-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-22-148057 2022-05-12T07:14:28-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-22-009590 2022-05-12T14:25:31-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-22-148643 2022-05-12T16:15:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-012305 2022-05-12T20:32:24-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-012306 2022-05-12T20:32:24-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-012308 2022-05-12T20:32:24-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-012303 2022-05-12T20:32:25-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-012307 2022-05-12T20:32:31-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-012309 2022-05-12T20:32:35-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-012304 2022-05-12T20:32:39-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-22-016881 2022-08-11T16:17:58-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-22-016917 2022-08-11T16:37:19-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-22-244248 2022-09-14T07:08:15-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b5/0001193125-22-244264 2022-09-14T07:31:33-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-22-244317 2022-09-14T09:04:30-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13da/0001193805-22-001271 2022-09-16T17:22:09-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-019646 2022-09-19T07:03:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-019645 2022-09-19T07:03:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-22-019753 2022-09-20T06:58:53-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001193805-22-001295 2022-09-20T20:44:55-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-22-001296 2022-09-20T20:44:57-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-22-019769 2022-10-20T08:12:50-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-22-024139 2022-11-10T07:04:21-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-22-024223 2022-11-10T09:24:58-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-3/0001193125-22-282600 2022-11-10T17:18:58-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001104659-22-118669 2022-11-14T16:45:17-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/effect/9999999995-22-003366 2022-11-22T06:07:50-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/upload/0000000000-22-012442 2022-12-21T00:09:13-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/corresp/0001193125-22-288978 2022-12-21T00:09:20-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-23-000506 2023-01-09T16:07:11-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001493152-23-002084 2023-01-23T06:08:34-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-23-003734 2023-02-02T20:26:33-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-23-003735 2023-02-02T20:27:18-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-23-026958 2023-02-07T16:24:35-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0000899243-23-004434 2023-02-09T17:03:06-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0000899243-23-004438 2023-02-09T17:11:15-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001085146-23-001072 2023-02-13T12:05:52-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001193125-23-038711 2023-02-14T14:32:14-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-23-069624 2023-03-14T07:54:54-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-k/0000950170-23-007855 2023-03-14T16:07:04-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-23-070249 2023-03-14T17:17:41-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-23-070247 2023-03-14T17:17:42-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13da/0001193805-23-000345 2023-03-17T06:12:39-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-23-093965 2023-04-06T16:09:08-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/def-14a/0001193125-23-097798 2023-04-11T16:08:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/ars/0001193125-23-097802 2023-04-11T16:11:48-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-23-010806 2023-05-11T16:31:47-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-23-010805 2023-05-11T16:31:48-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-23-010808 2023-05-11T16:35:20-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-23-010807 2023-05-11T16:35:21-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-23-000711 2023-05-11T18:34:44-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-23-021747 2023-05-12T16:08:28-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-23-021953 2023-05-15T07:11:09-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-23-022187 2023-05-15T16:09:59-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-23-011545 2023-05-18T14:15:47-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-23-011547 2023-05-18T14:15:47-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-23-011546 2023-05-18T14:18:02-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-23-025691 2023-06-01T16:09:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-23-033196 2023-07-17T16:10:32-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001062993-23-014992 2023-07-18T16:17:03-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-23-014993 2023-07-18T16:17:47-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/144/0001972362-23-000497 2023-07-24T17:50:34-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-23-034217 2023-07-25T07:04:11-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-23-040946 2023-08-11T15:20:12-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-23-041293 2023-08-10T16:09:50-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-23-042070 2023-08-14T08:07:30-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001274173-23-000087 2023-08-18T14:46:55-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-23-249962 2023-10-03T16:32:14-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/3/0001062993-23-019065 2023-10-05T16:34:07-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-23-019067 2023-10-05T16:37:33-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-23-063347 2023-11-14T07:44:20-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-23-063517 2023-11-14T14:03:32-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-23-022200 2023-12-08T16:11:23-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-24-001084 2024-01-19T16:34:04-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-24-001083 2024-01-19T16:34:21-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-24-001085 2024-01-19T16:36:16-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-24-001086 2024-01-19T16:41:29-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-013563 2024-02-12T07:07:47-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b5/0001193125-24-033870 2024-02-13T16:47:23-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001274173-24-000054 2024-02-13T17:35:03-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-014919 2024-02-14T06:08:56-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001140361-24-007732 2024-02-14T08:57:13-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001193125-24-036429 2024-02-14T16:47:55-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b5/0001193125-24-036565 2024-02-14T17:09:57-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001140361-24-008095 2024-02-14T21:02:19-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-24-003312 2024-02-15T16:24:23-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13da/0001193805-24-000234 2024-02-15T17:23:28-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13da/0001193805-24-000244 2024-02-16T14:14:41-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-24-000245 2024-02-16T14:40:58-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-24-038473 2024-02-16T16:07:43-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0001104659-24-027515 2024-02-26T16:20:08-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-029236 2024-03-11T16:12:32-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-031467 2024-03-14T16:09:00-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-k/0000950170-24-031529 2024-03-14T16:28:28-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-24-068008 2024-03-14T17:08:41-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-24-068011 2024-03-14T17:08:50-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13da/0001193805-24-000378 2024-03-15T16:42:36-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/pre-14a/0001193125-24-093837 2024-04-12T06:11:20-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/def-14a/0001193125-24-122191 2024-04-29T16:08:30-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/ars/0001193125-24-122206 2024-04-29T16:09:43-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-056248 2024-05-09T07:09:46-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-24-056965 2024-05-09T16:16:29-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-3/0001193125-24-135337 2024-05-09T16:52:07-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-062387 2024-05-20T16:10:20-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/effect/9999999995-24-001647 2024-05-28T06:12:05-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-066571 2024-05-30T16:09:46-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-067306 2024-05-31T16:09:26-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-24-011572 2024-05-31T16:59:53-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-24-011571 2024-05-31T16:59:57-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-24-011568 2024-05-31T16:59:57-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-24-011569 2024-05-31T17:00:04-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-24-011570 2024-05-31T17:00:15-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-24-000743 2024-06-03T18:33:41-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-071056 2024-06-10T06:16:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/upload/0000000000-24-005680 2024-06-26T00:08:35-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/corresp/0001193125-24-145160 2024-06-26T00:08:36-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-092265 2024-08-07T07:05:29-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-24-093733 2024-08-08T14:42:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-118586 2024-10-30T07:10:41-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-24-119100 2024-10-30T17:06:25-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13g/0000769993-24-000350 2024-11-06T14:32:54-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0000905148-24-003078 2024-11-14T09:19:32-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001274173-24-000112 2024-11-14T11:49:47-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/sc-13ga/0001140361-24-046973 2024-11-14T17:06:53-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-127768 2024-11-18T07:07:13-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-24-136384 2024-12-16T07:06:05-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/0001274173-25-000006 2025-01-08T11:51:16-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-25-003794 2025-01-10T07:27:42-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-25-001078 2025-01-24T16:17:57-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-25-001077 2025-01-24T16:18:11-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-25-001079 2025-01-24T16:18:27-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-25-001080 2025-01-24T16:18:35-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-25-009196 2025-01-27T16:14:04-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/0002012383-25-000662 2025-02-04T15:47:01-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-25-043487 2025-03-24T07:07:23-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-k/0000950170-25-043925 2025-03-24T16:54:33-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-25-061462 2025-03-24T17:21:58-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/def-14a/0000950170-25-053028 2025-04-11T07:45:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/ars/0000950170-25-053030 2025-04-11T07:47:05-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13g/0001641172-25-005093 2025-04-16T17:15:08-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13ga/0002052113-25-000404 2025-04-22T14:29:52-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-25-060563 2025-04-30T07:03:56-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-25-061222 2025-04-30T17:08:59-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-25-063125 2025-05-05T06:36:41-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13ga/0000769993-25-000286 2025-05-13T11:35:37-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-25-070287 2025-05-13T16:07:27-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13ga/0001274173-25-000147 2025-05-14T12:28:39-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-25-009376 2025-05-14T16:36:07-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-25-009379 2025-05-14T16:36:07-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-25-009377 2025-05-14T16:36:07-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-25-009378 2025-05-14T16:36:07-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001062993-25-009380 2025-05-14T16:36:13-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-25-000672 2025-05-15T19:50:33-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13g/0001104659-25-060256 2025-06-17T16:14:23-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-25-088704 2025-06-23T07:36:24-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-25-089074 2025-06-23T17:17:04-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b5/0001193125-25-168035 2025-07-29T16:38:13-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-25-168096 2025-07-29T17:03:58-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-25-169818 2025-07-31T06:13:10-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b5/0001193125-25-169661 2025-07-31T06:13:21-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13da/0001193805-25-001138 2025-07-31T18:30:39-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-25-001155 2025-08-04T18:30:35-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0000950170-25-108409 2025-08-14T07:06:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13ga/0001274173-25-000204 2025-08-14T10:48:29-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0000950170-25-108797 2025-08-14T15:38:36-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13g/0001641172-25-025979 2025-08-29T16:06:33-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-25-221538 2025-09-29T07:07:06-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-25-237998 2025-10-14T07:07:37-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-25-265702 2025-11-05T07:08:12-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-q/0001193125-25-266969 2025-11-05T16:20:21-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13ga/0001104659-25-107757 2025-11-06T16:18:27-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-25-273217 2025-11-10T07:09:33-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-25-321738 2025-12-17T08:08:30-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-26-010409 2026-01-12T16:21:25-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-26-018664 2026-01-22T07:02:41-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193125-26-024824 2026-01-27T17:05:57-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193125-26-024833 2026-01-27T17:05:57-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193125-26-024832 2026-01-27T17:05:57-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193125-26-024826 2026-01-27T17:06:06-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13ga/0001140361-26-005033 2026-02-12T16:37:49-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13ga/0001346824-26-000047 2026-02-17T16:35:05-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-26-065186 2026-02-24T07:07:05-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b5/0001193125-26-071493 2026-02-25T16:08:36-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/424b5/0001193125-26-076775 2026-02-26T16:27:08-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-26-077646 2026-02-27T06:15:34-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193125-26-085515 2026-03-02T16:34:40-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193125-26-085514 2026-03-02T16:34:41-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193125-26-085510 2026-03-02T16:34:58-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/schedule-13da/0001193805-26-000206 2026-03-02T19:49:20-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/4/0001193805-26-000205 2026-03-02T19:50:54-05:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-26-098493 2026-03-09T16:16:49-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/8-k/0001193125-26-115119 2026-03-19T07:06:55-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/10-k/0001193125-26-115878 2026-03-19T15:45:39-04:00 0.4 https://investors.larimartx.com/sec-filings/sec-filing/s-8/0001193125-26-116159 2026-03-19T17:04:26-04:00 0.4 https://investors.larimartx.com/board-directors/frank-thomas 2025-10-13T18:17:27-04:00 0.5 https://investors.larimartx.com/board-directors/tom-hamilton 2025-10-13T18:17:38-04:00 0.5 https://investors.larimartx.com/board-directors/joe-truitt 2025-10-13T18:17:34-04:00 0.5 https://investors.larimartx.com/board-directors/jonathan-leff 2025-10-13T18:17:22-04:00 0.5 https://investors.larimartx.com/analyst/myles-r-minter-phd 2024-10-03T09:41:13-04:00 0.5 https://investors.larimartx.com/analyst/jonathan-wolleben 2021-10-18T14:31:24-04:00 0.5 https://investors.larimartx.com/analyst/patrick-dolezal-ms 2024-10-03T08:52:25-04:00 0.5 https://investors.larimartx.com/analyst/yatin-suneja 2023-07-25T17:21:06-04:00 0.5 https://investors.larimartx.com/analyst/samantha-semenkow-phd 2024-10-03T08:53:35-04:00 0.5 https://investors.larimartx.com/board-directors/jeffrey-sherman 2025-10-13T18:20:09-04:00 0.5 https://investors.larimartx.com/analyst/joori-park 2024-10-02T14:49:59-04:00 0.5 https://investors.larimartx.com/analyst/catherine-novack 2024-10-02T14:53:25-04:00 0.5 https://investors.larimartx.com/analyst/laura-chico 2024-10-03T09:12:08-04:00 0.5 https://investors.larimartx.com/analyst/andreas-argyrides 2025-07-30T15:36:43-04:00 0.5 https://investors.larimartx.com/analyst/chris-chen 2025-07-31T09:54:21-04:00 0.5 https://investors.larimartx.com/analyst/joon-lee 2025-07-31T09:55:10-04:00 0.5 https://investors.larimartx.com/jeff-sherman 2025-10-13T18:16:33-04:00 0.5